Why have extracorporeal carbon dioxide removal clinical trials failed?

Puntos clave

• Current evidence does not support extracorporeal carbon dioxide removal for routine clinical use, highlighting its challenges.
• Despite theoretical advantages, potential complications reduce the effectiveness of ECCO2R interventions.
• Trial outcomes lack significant benefit, indicating a disconnect between expected and observed results in patients.
• Complications from ECCO2R procedures necessitate careful consideration before approaching clinical application.